Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)

Clinical trial NCT00280631 · COMPLETED

Trial details

NCT number: NCT00280631
Sponsor: Telik
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)

Start date: 2006-02-01
Primary completion: 2008-03-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.